Europe Neurology Clinical Trials Market

The Europe neurology clinical trials market encompasses the research and development of new drugs, therapies, and medical devices for nervous system conditions like Alzheimer's and Parkinson's. The primary customers are pharmaceutical companies, research institutions, and hospitals conducting these trials. Key growth drivers include significant government funding through programs like Horizon Europe, access to world-class medical research infrastructure, and an increasing demand for real-world data on treatment outcomes.